Sherman AC, van Haren SD, Borberg E, Swank Z, et al. Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. Vaccine 2024 Jun 10:S0264-410X(24)00695-9. doi: 10.1016/j.vaccine.2024.
PMID: 38862310